Skip to main content
DNTH logo

DNTH · Dianthus Therapeutics, Inc. · Debt

Track DNTH — free
$91.81 -0.67 (-0.72%) At close · Nov 13 Play latest call Q4 2025 earnings call transcript
Market Cap
$5.17B
Shares
56.31M
Volume · Nov 13 681.54K Avg daily vol (3M) 846.68K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-09-30 USD 1,208,000 10-Q filed 2026-11-04
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 349,000
Noncurrent operating lease liabilities
USD 859,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1690585 CUSIP 252828108 13F (30d) 195 filings 182 filers Visit website Investor relations